Garvagliptin is a DPP-4 inhibitor with demonstrated antidiabetic properties. It is used in research to study glucose metabolism and has shown efficacy in both in vitro enzymatic assays and in vivo models of type 2 diabetes.
Molekulargewicht:
399.46
CAS Nummer:
[1601479-87-1]
Formel:
C18H23F2N3O3S
Target-Kategorie:
Others,Proteasome
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten